261 related articles for article (PubMed ID: 28757166)
21. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
[TBL] [Abstract][Full Text] [Related]
22. Engineered telomere degradation models dyskeratosis congenita.
Hockemeyer D; Palm W; Wang RC; Couto SS; de Lange T
Genes Dev; 2008 Jul; 22(13):1773-85. PubMed ID: 18550783
[TBL] [Abstract][Full Text] [Related]
23. Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
Raval A; Behbehani GK; Nguyen le XT; Thomas D; Kusler B; Garbuzov A; Ramunas J; Holbrook C; Park CY; Blau H; Nolan GP; Artandi SE; Mitchell BS
PLoS One; 2015; 10(7):e0131722. PubMed ID: 26133370
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Dalle JH; Peffault de Latour R
Int J Hematol; 2016 Apr; 103(4):373-9. PubMed ID: 26872907
[TBL] [Abstract][Full Text] [Related]
25. Essential roles for Pot1b in HSC self-renewal and survival.
Wang Y; Shen MF; Chang S
Blood; 2011 Dec; 118(23):6068-77. PubMed ID: 21948176
[TBL] [Abstract][Full Text] [Related]
26. Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
Gu BW; Fan JM; Bessler M; Mason PJ
Aging Cell; 2011 Apr; 10(2):338-48. PubMed ID: 21241452
[TBL] [Abstract][Full Text] [Related]
27. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
Pereboeva L; Hubbard M; Goldman FD; Westin ER
PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
[TBL] [Abstract][Full Text] [Related]
28. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment.
Hartwig FP; Collares T
Ageing Res Rev; 2013 Mar; 12(2):642-52. PubMed ID: 23541441
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
30. Recent progress in dyskeratosis congenita.
Nishio N; Kojima S
Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
[TBL] [Abstract][Full Text] [Related]
31. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Choo S; Lorbeer FK; Regalado SG; Short SB; Wu S; Rieser G; Bertuch AA; Hockemeyer D
Blood; 2022 Aug; 140(6):608-618. PubMed ID: 35421215
[TBL] [Abstract][Full Text] [Related]
32. Telomere dysfunction in human bone marrow failure syndromes.
Shtessel L; Ahmed S
Nucleus; 2011; 2(1):24-9. PubMed ID: 21647296
[TBL] [Abstract][Full Text] [Related]
33. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Hoffman H; Rice C; Skordalakes E
J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the telomere capping complex in bone marrow failure and related syndromes.
Walne AJ; Bhagat T; Kirwan M; Gitiaux C; Desguerre I; Leonard N; Nogales E; Vulliamy T; Dokal IS
Haematologica; 2013 Mar; 98(3):334-8. PubMed ID: 22899577
[TBL] [Abstract][Full Text] [Related]
35. p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.
Rakotopare J; Toledo F
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834388
[TBL] [Abstract][Full Text] [Related]
36. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
Gramatges MM; Bertuch AA
Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
[TBL] [Abstract][Full Text] [Related]
37. Dyskeratosis congenita and telomerase.
Bessler M; Wilson DB; Mason PJ
Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
[TBL] [Abstract][Full Text] [Related]
38. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
Vulliamy TJ; Knight SW; Mason PJ; Dokal I
Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
[TBL] [Abstract][Full Text] [Related]
39. Dyskeratosis congenita.
Savage SA; Alter BP
Hematol Oncol Clin North Am; 2009 Apr; 23(2):215-31. PubMed ID: 19327580
[TBL] [Abstract][Full Text] [Related]
40. Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline.
Graniel JV; Bisht K; Friedman A; White J; Perkey E; Vanderbeck A; Moroz A; Carrington LJ; Brandstadter JD; Allen F; Shami AN; Thomas P; Crayton A; Manzor M; Mychalowych A; Chase J; Hammoud SS; Keegan CE; Maillard I; Nandakumar J
Life Sci Alliance; 2022 Jan; 5(1):. PubMed ID: 34645668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
